Rafferty Asset Management, LLC Novavax Inc Transaction History
Rafferty Asset Management, LLC
- $26.8 Billion
- Q2 2024
A detailed history of Rafferty Asset Management, LLC transactions in Novavax Inc stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 261,872 shares of NVAX stock, worth $3.05 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
261,872
Previous 1,682,659
84.44%
Holding current value
$3.05 Million
Previous $8.04 Million
58.78%
% of portfolio
0.01%
Previous 0.03%
Shares
17 transactions
Others Institutions Holding NVAX
# of Institutions
284Shares Held
83.2MCall Options Held
5.43MPut Options Held
9M-
Vanguard Group Inc Valley Forge, PA14.1MShares$164 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$138 Million0.0% of portfolio
-
Shah Capital Management9.66MShares$112 Million41.87% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY6.32MShares$73.5 Million0.08% of portfolio
-
State Street Corp Boston, MA6.07MShares$70.5 Million0.0% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $910M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...